BCYC vs CE · rev $35.3M vs rev $10.28B
Bicycle Therapeutics Ltd (BCYC) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported BCYC revenue for 2024-12-31 was $35.3M. Net income was -$169.0M. Revenue was up 30.8% from 2023-12-31 to 2024-12-31. BCYC currently screens at market cap $554.0M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
BCYC currently screens at market cap $554.0M. CE currently screens at market cap $5.92B.
Not investment advice. Open the BCYC and CE stock pages for the full models.
Not investment advice.